Using Mounjaro: what actually happens once you start

The first injection: what the next 48 hours look like

You've read the leaflet, the pen is out of the fridge, and you're sitting on the edge of the bath wondering how this actually feels. That scenario is one our prescribers hear about most weeks, the gap between reading about Mounjaro and doing the first injection is wider than people expect.

The injection itself is straightforward: a subcutaneous jab into the abdomen, outer thigh, or upper arm. Rotate sites from week to week to avoid any local irritation. The pen does most of the work; there's no needle to attach or plunger to push. For a detailed walkthrough of the process, the first-time Mounjaro injection guide covers the steps clearly.

In the 24 to 48 hours after that first 2.5 mg dose, many people feel nothing at all. Others notice mild nausea, a reduced appetite, or some fatigue. These are the body's normal responses to a medicine that slows gastric emptying and dials down hunger signals. They're not a sign something has gone wrong. Keep meals smaller, stay well hydrated, and give it a few days before drawing any conclusions. The 2.5 mg dose is designed for tolerability, not for immediate weight loss, your prescriber will review progress before each increase. The practical tips page has useful advice on managing that first week.

Weeks two to eight: settling in and what shifts

By the second or third injection, most people notice something has changed in how they feel around food. Hunger becomes quieter. The pull toward snacking after dinner fades. Portion sizes that once felt small start to feel right. This is the GIP and GLP-1 receptor activity doing its job, described by the NHS tirzepatide medicines page as increasing feelings of fullness and reducing appetite alongside slowing gastric emptying.

The dose increase from 2.5 mg to 5 mg typically happens after four weeks, but only once your prescriber is satisfied with tolerability. Side effects, if they appeared early, usually settle before the increase lands. If nausea or digestive discomfort is still troublesome, that's information your prescriber needs, a dose hold is a legitimate clinical choice, not a failure.

Weight change in this window tends to be gradual. Some people lose two or three kilograms in the first month; others less. The SURMOUNT-1 trial, published in the New England Journal of Medicine, reported average reductions of around 20–21% at the 15 mg dose over 72 weeks, but those results came at the end of a long, carefully titrated treatment course, not in week four. Comparing your early progress to a 72-week endpoint is the wrong measure. Keep the focus on how you're tolerating treatment and what your prescriber says at each review.

Month two onward: dose increases and the longer picture

The dose titration schedule moves in roughly four-week steps: 2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, up to a maximum of 15 mg. Each increase is a clinical decision, not automatic. Your prescriber looks at tolerability, any side effects, and your overall progress before moving up. Some people stay at 5 mg or 7.5 mg long-term because that's where the balance between effect and tolerability sits best for them. The available UK strengths and what drives titration decisions are covered in more detail on the tirzepatide treatment overview.

Around the 30-day mark, a question that comes up frequently is whether the medicine is working as expected. The Mounjaro after 30 days page addresses this honestly, including what typical progress looks like and when it's worth raising concerns with your prescriber. A related question is whether the injection day can shift slightly, the guidance on taking Mounjaro a day early explains the flexibility and limits there.

There are also situations where stopping becomes relevant, planned surgery, pregnancy planning, or simply reaching a point where you and your prescriber agree treatment has run its course. Stopping isn't something to do unilaterally; there's a right way to approach it, which the stopping Mounjaro guide covers in full.

Safety checks worth keeping in mind throughout

A few things are worth knowing before they become urgent. Oral contraceptive pill users need an additional non-oral method for the first four weeks of treatment and for four weeks after each dose increase. This is because Mounjaro can reduce how much of the pill your gut absorbs. Transdermal HRT (patches or gels) is worth discussing with your doctor for the same reason, per NHS England guidance on weight management medicines.

Pancreatitis is a rare but serious risk with GLP-1 class medicines. Severe stomach pain that spreads to the back, with or without vomiting, is the key symptom to act on quickly, don't wait and see, seek medical help the same day. The MHRA issued a Drug Safety Update in January 2026 specifically highlighting this, and it's flagged in the MHRA Yellow Card reporting system where patients can also report any other suspected side effects.

Mounjaro should be kept refrigerated between 2°C and 8°C. If you need to travel with it, check the Patient Information Leaflet for the exact room-temperature storage window, the specific timeframe is there, and it varies by circumstance. For questions about the service, the cost of private treatment, or anything else before you start, the Mounjaro cost page covers what private treatment involves. When you're ready to check your suitability with a clinician, speak to our prescribers through a free consultation, reviewed the same day by a GPhC-registered Independent Prescriber.